Publication | Closed Access

The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial

Neuro-oncologyOncologyHealth-related QualityCancer ManagementClinical TrialsBelob TrialNeurologyHigh-grade GliomasCancer TreatmentRecurrent GlioblastomaMedicineGlioma